Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study

Main Article Content

Michihiro Hide
Hae-Sim Park
Atsuyuki Igarashi
Young-Min Ye
Tae-Bum Kim
Akiko Yagami

Keywords

omalizumab, efficacy, safety, clinical trial, urticaria

Abstract

Abstract Not Available